These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A traceback phenomenon can reveal the origin of prion infection. Kobayashi A; Asano M; Mohri S; Kitamoto T Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941 [TBL] [Abstract][Full Text] [Related]
4. Transmission Properties of Human PrP 102L Prions Challenge the Relevance of Mouse Models of GSS. Asante EA; Grimshaw A; Smidak M; Jakubcova T; Tomlinson A; Jeelani A; Hamdan S; Powell C; Joiner S; Linehan JM; Brandner S; Wadsworth JD; Collinge J PLoS Pathog; 2015 Jul; 11(7):e1004953. PubMed ID: 26135918 [TBL] [Abstract][Full Text] [Related]
5. Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions. Chapuis J; Moudjou M; Reine F; Herzog L; Jaumain E; Chapuis C; Quadrio I; Boulliat J; Perret-Liaudet A; Dron M; Laude H; Rezaei H; Béringue V Acta Neuropathol Commun; 2016 Feb; 4():10. PubMed ID: 26847207 [TBL] [Abstract][Full Text] [Related]
13. Inherited prion diseases and transmission to rodents. Tateishi J; Kitamoto T Brain Pathol; 1995 Jan; 5(1):53-9. PubMed ID: 7767491 [TBL] [Abstract][Full Text] [Related]
14. Identification of I137M and other mutations that modulate incubation periods for two human prion strains. Giles K; De Nicola GF; Patel S; Glidden DV; Korth C; Oehler A; DeArmond SJ; Prusiner SB J Virol; 2012 Jun; 86(11):6033-41. PubMed ID: 22438549 [TBL] [Abstract][Full Text] [Related]
15. A naturally occurring variant of the human prion protein completely prevents prion disease. Asante EA; Smidak M; Grimshaw A; Houghton R; Tomlinson A; Jeelani A; Jakubcova T; Hamdan S; Richard-Londt A; Linehan JM; Brandner S; Alpers M; Whitfield J; Mead S; Wadsworth JD; Collinge J Nature; 2015 Jun; 522(7557):478-81. PubMed ID: 26061765 [TBL] [Abstract][Full Text] [Related]
16. Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes. Ward A; Hollister JR; McNally K; Ritchie DL; Zanusso G; Priola SA Acta Neuropathol Commun; 2020 Jun; 8(1):83. PubMed ID: 32517816 [TBL] [Abstract][Full Text] [Related]
17. Prion protein transgenes and the neuropathology in prion diseases. DeArmond SJ; Prusiner SB Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493 [TBL] [Abstract][Full Text] [Related]
18. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases. Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818 [TBL] [Abstract][Full Text] [Related]
19. Distinct glycoform ratios of protease resistant prion protein associated with PRNP point mutations. Hill AF; Joiner S; Beck JA; Campbell TA; Dickinson A; Poulter M; Wadsworth JD; Collinge J Brain; 2006 Mar; 129(Pt 3):676-85. PubMed ID: 16415305 [TBL] [Abstract][Full Text] [Related]
20. Experimental verification of a traceback phenomenon in prion infection. Kobayashi A; Sakuma N; Matsuura Y; Mohri S; Aguzzi A; Kitamoto T J Virol; 2010 Apr; 84(7):3230-8. PubMed ID: 20089646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]